Epigenetically Altered T Cells Contribute to Lupus Flares
AbstractLupus flares when genetically predisposed people encounter exogenous agents such as infections and sun exposure and drugs such as procainamide and hydralazine, but the mechanisms by which these agents trigger the flares has been unclear. Current evidence indicates that procainamide and hydralazine, as well as inflammation caused by the environmental agents, can cause overexpression of genes normally silenced by DNA methylation in CD4+ T cells, converting them into autoreactive, proinflammatory cytotoxic cells that are sufficient to cause lupus in mice, and similar cells are found in patients with active lupus. More recent studies demonstrate that these cells comprise a distinct CD4+ T cell subset, making it a therapeutic target for the treatment of lupus flares. Transcriptional analyses of this subset reveal proteins uniquely expressed by this subset, which may serve as therapeutic to deplete these cells, treating lupus flares. View Full-Text
Share & Cite This Article
Richardson, B. Epigenetically Altered T Cells Contribute to Lupus Flares. Cells 2019, 8, 127.
Richardson B. Epigenetically Altered T Cells Contribute to Lupus Flares. Cells. 2019; 8(2):127.Chicago/Turabian Style
Richardson, Bruce. 2019. "Epigenetically Altered T Cells Contribute to Lupus Flares." Cells 8, no. 2: 127.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.